HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Inhibitory effects of 22-oxa-calcitriol and all- trans retinoic acid on the growth of a canine osteosarcoma derived cell-line in vivo and its pulmonary metastasis in vivo.

Abstract
Pulmonary metastasis is a major cause of death and a major obstacle to the successful treatment of canine osteosarcoma. However, the residual capacity of the neoplasia for differentiation and its susceptibility to undergo apoptosis may be used to suppress its growth and metastatic properties. The highly metastasizing POS (HMPOS) canine osteosarcoma cell line which preferentially metastasize to the lungs was used to test the possible efficacy of 22-oxa-calcitriol (OCT) and all- trans retinoic acid (ATRA) to inhibit growth and pulmonary metastasis of the subcutaneously grown osteosarcoma in nude mice. Treatments in vitro, morphologically elongated and increased alkaline phosphatase activity and staining of cells. Tumour growth in vivo was inhibited significantly and the combination treatment of OCT and ATRA (OCT + ATRA) exerted a synergistic and stronger suppression at concentration of 1.0 microg kg(-1)body weight when given subcutaneously three times a week for 5 weeks. The subcutaneous tumours of the control mice consisted of osteoblast-like cells and isolated chondroblast-like cells, but formed several areas of osteoid and increased amount of collagen tissue in all treated mice. Pinpoint macrometastatic nodules developed only in all control mice. Micrometastatic nodule developed only in two of six mice treated with ATRA. However, nodule size and number, and lung wet weight were all reduced significantly. Metastasis were not seen in the mice treated with OCT or OCT + ATRA. This study demonstrated that inhibition of growth and pulmonary metastasis was induced by subcutaneous treatment with these drugs and suggest that both its differentiating and apoptotic inducing activities may be responsible for the antitumour effects. These drugs may be useful in the clinic as an adjunct for the treatment of canine osteosarcoma.
AuthorsE F Barroga, T Kadosawa, M Okumura, T Fujinaga
JournalResearch in veterinary science (Res Vet Sci) Vol. 68 Issue 1 Pg. 79-87 (Feb 2000) ISSN: 0034-5288 [Print] ENGLAND
PMID10684763 (Publication Type: Journal Article)
CopyrightCopyright 2000 Harcourt Publishers LtdCopyright 2000 Harcourt Publishers Ltd.
Chemical References
  • Antineoplastic Agents
  • Biomarkers
  • maxacalcitol
  • Tretinoin
  • Alkaline Phosphatase
  • Calcitriol
Topics
  • Alkaline Phosphatase (analysis)
  • Animals
  • Antineoplastic Agents (therapeutic use, toxicity)
  • Biomarkers (analysis)
  • Bone Neoplasms (drug therapy, pathology, veterinary)
  • Calcitriol (analogs & derivatives, therapeutic use, toxicity)
  • Cell Division (drug effects)
  • Dog Diseases (drug therapy, pathology)
  • Dogs
  • Female
  • Lung Neoplasms (drug therapy, pathology, secondary, veterinary)
  • Mice
  • Mice, Nude
  • Osteosarcoma (pathology, secondary, veterinary)
  • Transplantation, Heterologous
  • Tretinoin (therapeutic use, toxicity)
  • Tumor Cells, Cultured

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: